Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Patients with non-small cell lung cancer with an activating EGFR mutation in the tumor, are treated with targeted therapy against this mutation. In the end, all patients develop resistance against this therapy, but some patients have a very short or no benefit. In this study, the aut...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Steendam, Christi M. J., Veerman, G. D. Marijn, Pruis, Melinda A., Atmodimedjo, Peggy, Paats, Marthe S., van der Leest, Cor, von der Thüsen, Jan H., Yick, David C. Y., Oomen-de Hoop, Esther, Koolen, Stijn L. W., Dinjens, Winand N. M., van Schaik, Ron H. N., Mathijssen, Ron H. J., Aerts, Joachim G. J. V., Dubbink, Hendrikus Jan, Dingemans, Anne-Marie C.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692448/
https://ncbi.nlm.nih.gov/pubmed/33138052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113179
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares